How have CUBT shares performed in 2024?

Curative Biotechnology's stock was trading at $0.0213 at the beginning of the year. Since then, CUBT shares have increased by 20.2% and is now trading at $0.0256. View the best growth stocks for 2024 here .

Are investors shorting Curative Biotechnology?

Curative Biotechnology saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,300 shares, an increase of 175.0% from the March 15th total of 1,200 shares. Based on an average trading volume of 91,400 shares, the days-to-cover ratio is currently 0.0 days. View Curative Biotechnology's Short Interest .

When is Curative Biotechnology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024. View our CUBT earnings forecast .

How do I buy shares of Curative Biotechnology?

Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CUBT

Curative Biotechnology (CUBT) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free CUBT Stock Alerts

$0.03

+0.00 (+11.30%)

(As of 04/15/2024 04:29 PM ET)

Compare

Today's Range: $0.03
▼
$0.03
50-Day Range: $0.02
▼
$0.04
52-Week Range: $0.01
▼
$0.04

Volume: 353,528 shs
Average Volume: 252,568 shs
Market Capitalization: $18.00 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings Short Interest

Get Curative Biotechnology alerts:

Ad Porter & Company

The #1 Investment of the Decade…

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

To get all the details of this controversial tech – click here now.

About Curative Biotechnology Stock (OTCMKTS:CUBT)

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

CUBT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CUBT Stock News Headlines

April 11, 2024 | americanbankingnews.com

Short Interest in Curative Biotechnology, Inc. (OTCMKTS:CUBT) Rises By 175.0%

March 31, 2024 | globenewswire.com

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

April 16, 2024 | Porter & Company (Ad)

The #1 Investment of the Decade…

March 29, 2024 | seekingalpha.com

SFRX Seafarer Exploration Corp.

March 22, 2024 | globenewswire.com

Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors

January 22, 2024 | insidermonkey.com

Should You Expect Strong Financial Growth For Legend Biotech Corporation (LEGN)?

October 31, 2023 | finanznachrichten.de

Curative Biotechnology, Inc.?: Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors

August 18, 2023 | thestreet.com

3 Best Biotech Stocks to Add to Your Portfolio

April 16, 2024 | Porter & Company (Ad)

The #1 Investment of the Decade…

June 6, 2023 | finance.yahoo.com

Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions

June 2, 2023 | bizjournals.com

Sacramento Biotech News

May 24, 2023 | finance.yahoo.com

Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation

January 5, 2023 | finanznachrichten.de

Curative Biotechnology, Inc.?: Curative Biotechnology Announces Completion of IND Enabling Reformulated Metformin HCL Eye Drop Study

November 12, 2022 | finance.yahoo.com

Curative Biotechnology, Inc. (CUBT)

November 8, 2022 | seekingalpha.com

Curative Biotechnology refiles for NYSE uplisting, $8M offering

October 20, 2022 | finanznachrichten.de

Curative Biotechnology, Inc.: Curative Biotechnology Announces Intent to Uplist to NYSE American Exchange

September 30, 2022 | seekingalpha.com

Curative Biotechnology files for NYSE American uplisting, $8M IPO

September 26, 2022 | benzinga.com

Curative Biotechnology Stock (OTC:CUBT), Short Interest Report

September 22, 2022 | seekingalpha.com

CUBT Curative Biotechnology, Inc.

June 16, 2022 | finance.yahoo.com

Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors

May 12, 2022 | finance.yahoo.com

Curative Biotechnology, Inc. Names Cary Sucoff to Board of Directors

May 12, 2022 | finance.yahoo.com

Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors

May 4, 2022 | yahoo.com

Can You Pay a Mortgage With a Credit Card?

May 3, 2022 | finance.yahoo.com

Curative Biotechnology Announces Good Laboratory Practice (GLP) Toxicology Studies with Metformin Eye Drop Formulations for Treatment of Macular Degeneration

May 3, 2022 | finance.yahoo.com

Curative Biotechnology Announces Toxicology Studies Under Good Laboratory Practices (GLP) for Metformin Eye Drop Formulations for Treatment of Macular Degeneration

March 21, 2022 | seekingalpha.com

Curative signs agreement with NEI to develop age-related eye disease treatment

March 21, 2022 | morningstar.com

Emily Y. Chew, M.D. of the National Eye Institute Assigned Principal Investigator

See More Headlines

Receive CUBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Next Earnings (Estimated): 5/06/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Current Symbol: OTCMKTS:CUBT
CUSIP: N/A
CIK: 1400271
Web: curativebiotech.com
Phone: (561) 418-7725
Fax: 866-900-1002
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 703,260,000
Free Float: N/A
Market Cap: $18.00 million
Optionable: Not Optionable
Beta: -17.73

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

Paul M. Michael
Executive Chairman & President
I. Richard Garr
Chief Executive Officer & General Counsel
Ron Bordens
Executive VP-Technical Operations & Manufacturing
Barry A. Ginsberg
Vice Chairman & Chief Strategy Officer

Key Competitors

View All Competitors

CUBT Stock Analysis - Frequently Asked Questions

How have CUBT shares performed in 2024?: Curative Biotechnology's stock was trading at $0.0213 at the beginning of the year. Since then, CUBT shares have increased by 20.2% and is now trading at $0.0256.
View the best growth stocks for 2024 here.
Are investors shorting Curative Biotechnology?: Curative Biotechnology saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,300 shares, an increase of 175.0% from the March 15th total of 1,200 shares. Based on an average trading volume of 91,400 shares, the days-to-cover ratio is currently 0.0 days.
View Curative Biotechnology's Short Interest.
When is Curative Biotechnology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 6th 2024.
View our CUBT earnings forecast.
How do I buy shares of Curative Biotechnology?: Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CUBT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Curative Biotechnology (CUBT) Stock Price, News & Analysis

About Curative Biotechnology Stock (OTCMKTS:CUBT)

CUBT Stock Price History

CUBT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

CUBT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info